关键信息
-
基因名
CG alpha
- 应用
-
别名
ICSH; Lutropin; Interstitial Cell Stimulating Hormone
-
种属
Human
-
表达系统
HEK293
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P01215; P01229
-
表达区间
Ala25~Ser116+GGGGS*3+Ser21~Leu141
-
蛋白长度
Partial
-
分子量
37-38kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CG alpha recombinant protein, derived from the calcitonin gene (CALCA), has garnered significant interest in biomedical research due to its potential applications in various therapeutic areas. Calcitonin, originally identified as a hormone involved in calcium homeostasis, has been shown to possess neuroprotective and analgesic properties, making CG alpha a promising candidate for treating pain disorders and neurodegenerative conditions. Recombinant technology allows for the production of this protein in a controlled manner, facilitating studies on its structure-function relationships and biological activities. Additionally, the use of CG alpha in drug development is appealing because it can interact with a variety of receptors implicated in pain pathways. Research has also explored its potential role in modulating bone metabolism and cardiovascular health. As scientists delve deeper into the mechanisms of CG alpha, understanding its signaling pathways could lead to novel therapeutic strategies, particularly in conditions where traditional treatments have fallen short. Furthermore, advancements in recombinant protein production technology enhance the scalability and efficiency of CG alpha synthesis, paving the way for clinical applications. Overall, the ongoing research into CG alpha recombinant protein is poised to reveal important insights that could inform innovative treatments in medicine.
